CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Pharmaceutical Technology
High ImpactOriginal article

FDA approves Lilly’s Onswik for type 2 diabetes in adults

RegulatoryapprovedOnswikPositive
AI Analysis

Summary

The FDA has approved Eli Lilly's Onswik, a once-weekly basal insulin injection for adults with type 2 diabetes. This represents a new treatment option in the insulin therapy market.

Outcome Details

FDA approval for once-weekly basal insulin injection

Importance:8/10
Sentiment:
0.95
FDA approvaltype 2 diabetesinsulinLilly
Related Companies

Read the original article

Published by Pharmaceutical Technology on September 25, 2026 7:38 AM

Read Original